在晚期肝细胞癌中停止使用VEGF抑制剂后,单独使用免疫疗法的完整反应:一个病例报告
Mohammad Ss Naviwala1, Daania Shoaib1, Waqas A Khan1
1Department of Medical Oncology, Aga Khan University Hospital, Karachi, Sindh, Pakistan.
Euroasian journal of hepato-gastroenterology
|January 13, 2025
概括
晚期肝细胞癌 (HCC) 患者在因副作用而停止服用贝瓦齐祖马布后,可能会获得阿特佐利祖马布单一治疗的持续反应. 这表明,单独免疫疗法在特定的HCC病例中可能具有长期的疗效.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 肝细胞癌研究 肝细胞癌研究
背景情况:
- 与贝瓦西祖马布和阿特佐利祖马布的联合治疗是晚期肝细胞癌 (HCC) 的首选治疗方法.
- 对于HCC中任何一种药物的单一治疗的证据不太确立.
- 经过脊髓转移的高级HCC的管理存在重大挑战.
相关概念视频
Tumor Immunotherapy
469
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
469
Cancer Vaccines
336
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
336


